Use of surface-enhanced Raman scattering to quantify EGFR markers uninhibited by cetuximab antibodies

Biosensors and Bioelectronics

Volumn 60, Issue , 2014, Pages 358-365

  Chung, Eunsu ^a   Lee, Jiyoung ^a   Yu, Jimin ^a   Lee, Sangyeop ^a   Kang, Jin Hyun ^a   Chung, Il Yup ^a   Choo, Jaebum ^a  

^a Hanyang University   (South Korea)

Author keywords

Antibody drug; Cetuximab; EGFR; SERS; SERS imaging

Indexed keywords

AMINO ACIDS; CELL PROLIFERATION; CELLS; DIAGNOSIS; DISEASES; MONOCLONAL ANTIBODIES; RAMAN SCATTERING; SILICA;

ANTIBODY DRUGS; CELLULAR PROLIFERATIONS; CETUXIMAB; EGFR; EPIDERMAL GROWTH FACTOR RECEPTORS; MONOCLONAL ANTIBODY DRUGS; SERS; SURFACE ENHANCED RAMAN SCATTERING (SERS);

SURFACE SCATTERING;

CETUXIMAB; DRUG ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR; GOLD NANOPARTICLE; SILICON DIOXIDE; EGFR PROTEIN, HUMAN; MONOCLONAL ANTIBODY; TUMOR MARKER;

ARTICLE; BREAST CANCER CELL LINE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; MEASUREMENT ACCURACY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAMAN SPECTROMETRY; BREAST TUMOR; DEVICE FAILURE ANALYSIS; EQUIPMENT DESIGN; IMMUNOASSAY; IMMUNOLOGY; LIGHT; PROCEDURES; RADIATION SCATTERING; REFRACTOMETRY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SURFACE PLASMON RESONANCE; TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL, HUMANIZED; BREAST NEOPLASMS; CELL LINE, TUMOR; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HUMANS; IMMUNOASSAY; LIGHT; RECEPTOR, EPIDERMAL GROWTH FACTOR; REFRACTOMETRY; REPRODUCIBILITY OF RESULTS; SCATTERING, RADIATION; SENSITIVITY AND SPECIFICITY; SPECTRUM ANALYSIS, RAMAN; SURFACE PLASMON RESONANCE; TUMOR MARKERS, BIOLOGICAL;

EID: 84901049139     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2014.04.041     Document Type: Article

References (34)

1. Abulrob A., Lu Z., Baumann E., Vobornik D., Taylor R., Stanimirovic D., Johnston L.J. J. Biol. Chem. 2010, 285:3145-3156.
2. Allred D.C., Swanson P.E. Am. J. Clin. Pathol. 2000, 113:171-175.
3. Alvarez R.H., Valero V., Hortobagyi G.N. J. Clin. Oncol. 2010, 28:3366-3379.
4. Castillo L., Etienne-Grimaldi M.C., Fischel J.L., Formento P., Magne N., Milano G. Ann. Oncol. 2004, 15:1007-1012.
5. Citri A., Yarden Y. Nat. Rev. Mol. Cell Biol. 2006, 7:505-516.
6. Doering W.E., Nie S.M. Anal. Chem. 2003, 75:6171-6176.
7. Ferguson K.M. Ann. Rev. Biophys. 2008, 37:353-373.
8. Frens G. Nat. Phys. Sci. 1973, 241:20-22.
9. Huang J., Kim K.H., Choi N., Chon H., Lee S., Choo J. Langmuir 2011, 27:10228-10233.
10. Hynes N.E., Dey J.H. Cancer Res. 2010, 70:5199-5202.
11. Kennedy D.C., Hoop K.A., Tay I.I., Pezacki J.P. Nanoscale 2010, 2:1413-1416.
12. Kneipp K., Kneipp H., Kneipp J. Acc. Chem. Res. 2006, 39:443-450.
13. Ko J., Lee S., Lee E.K., Chang S.I., Chen L., Yoon S.Y., Choo J. Phys. Chem. Chem. Phys. 2013, 15:5379-5385.
14. Lee M., Kim K.H., Park J.G., Lee J.H., Lim H.W., Park M.Y., Chang S.I., Lee E.K., Lim D.W., Choo J. Biochip J. 2012, 6:10-16.
15. Lee M., Lee S., Lee J.H., Lim H.W., Seong G.H., Lee E.K., Chang S.I., Oh C.H., Choo J. Biosens. Bioelectron. 2011, 26:2135-2141.
16. Lee S., Chon H., Lee J., Ko J., Chung B.H., Lim D.W., Choo J. Biosens. Bioelectron. 2014, 51:238-243.
17. Lee S., Chon H., Lee M., Choo J., Shin S.Y., Lee Y.H., Rhyu I.J., Son S.W., Oh C.H. Biosens. Bioelectron. 2009, 24:2260-2263.
18. Lee S., Chon H., Yoon S.Y., Lee E.K., Chang S.I., Lim D.W., Choo J. Nanoscale 2012, 4:124-129.
19. Lee S., Kim S., Choo J., Shin S.Y., Lee Y.H., Choi H.Y., Ha S.H., Kang K.H., Oh C.H. Anal. Chem. 2007, 79:916-922.
20. Li S., Schmitz K.R., Jeffrey P.D., Wiltzius J.J.W., Kussie P., Ferguson K.M. Cancer Cell 2005, 7:301-311.
21. Manning H.C., Merchant N.B., Foutch A.C., Virostko J.M., Wyatt S.K., Shah C., McKinley E.T., Xie J., Mutic N.J., Washington M.K., LaFleur B., Tantawy M.N., Peterson T.E., Ansari M.S., Baldwin R.M., Rothenberg M.L., Bornhop D.J., Gore J.C., Coffey R.J. Clin. Cancer Res. 2008, 14:7413-7422.
22. Martinelli E., De Palma R., Orditura M., De Vita F., Ciardiello F. Clin. Exp. Immunol. 2009, 158:1-9.
23. Mulvaney S.P., Musick M.D., Keating C.D., Natan M.J. Langmuir 2003, 19:4784-4790.
24. Nahta R., Hortobagyi G.N., Esteva F.J. Oncologist 2003, 8:5-17.
25. Qian X.M., Nie S.M. Chem. Soc. Rev. 2008, 37:912-920.
26. Reilly R.M., Kiarash R., Sandhu J., Lee Y.W., Cameron R.G., Hendler A., Vallis K., Gariepy J. J. Nucl. Med. 2000, 41:903-911.
27. Rhodes A., Borthwick D., Sykes R., Al-Sam S., Paradiso A. Am. J. Clin. Pathol. 2004, 122:51-60.
28. Schütz M., Küstner B., Bauer M., Schmuck C., Schlücker S. Small 2010, 6:733-737.
29. Steinigeweg D., Schütz M., Schlücker S. Nanoscale 2013, 5:110-113.
30. Stöber W., Fink A., Bohn E. J. Colloid Interface Sci. 1968, 26:62-69.
31. Thomas T.P., Chang Y.C., Ye J.Y., Kotlyar A., Cao Z., Shukla R., Qin S., Norris T.B., Baker J.R. Cancer 2012, 118:2148-2156.
32. Wang S., Chen C., Meng Y., Hu S., Zheng L., Song J., Zhang D., Li B., Guo Y. Cancer Lett. 2012, 325:214-219.
33. Wolcott A., Gerion D., Visconte M., Sun J., Schwartzberg A., Chen S., Zhang J.Z. J. Phys. Chem. B 2006, 110:5779-5789.
34. Wolff A.C., Hammond M.E., Schwartz J.N. J. Clin. Oncol. 2007, 25:118-145.